688098 申联生物
2025/03 -
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资11,588632.03%1,5831,5861,5771,571
投资性房地产0--0000
固定资产749,60118.74%631,281658,335677,239634,215
在建工程58,996-66.83%177,871163,44398,949133,778
无形资产100,324-2.28%102,66493,59953,12132,660
商誉0--0000
其他非流动资产98,2139.26%89,88978,74268,69462,778
1,018,7221.54%1,003,287995,704899,580865,003

流动资产
货币资金96,484-34.01%146,20644,97652,74344,213
应收账款302,15915.59%261,398273,974222,153151,015
存货93,128-2.08%95,103111,789115,329103,421
其他流动资产50,1684.25%48,124167,552315,279434,813
541,939-1.61%550,831598,290705,504733,461

流动负债
短期借款14,0080.00%14,008000
应付票据0--0000
应付帐款9,11267.56%5,4385,1448,86011,333
其他流动负债105,2818.81%96,75571,35988,357102,197
128,40110.50%116,20176,50397,217113,529
流动资产净值413,538-4.85%434,629521,787608,287619,932
资产总额减流动负债1,432,260-0.39%1,437,9171,517,4911,507,8671,484,935

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债12,3720.63%12,29410,42310,99611,947
12,3720.63%12,29410,42310,99611,947

总权益
    实收股本410,6440.00%410,644410,644410,644410,644
    储备项目995,951-0.47%1,000,6511,078,0881,086,2271,068,233
股东权益1,406,595-0.33%1,411,2951,488,7321,496,8711,478,877
非控股权益13,293-7.22%14,32718,3360(5,890)